Researchers Find Potential New Gene Therapy for Blinding Disease (National Institutes of Health)
UF researchers Dr. Alfred Lewin and Dr. William Hauswirth, in collaboration with UPenn researchers, reported a gene therapy that may slow or prevent vision loss in people with a genetic blinding condition called autosomal dominant retinitis pigmentosa (AdRP). Scientists funded by the National Eye Institute (NEI) report a novel gene therapy that halts vision loss […]
U of Florida and Penn Ink Licensing Deal for Gene Therapy to Treat Retinal Disease (Tech Transfer eNews Blog)
Biotech company Ophthotech Corporation has entered into an exclusive global license agreement with the University of Florida Research Foundation (UFRF) and the University of Pennsylvania (Penn) to commercialize a treatment for a disease that causes blindness. The licensed technology is an adeno-associated virus (AAV) gene therapy to treat rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP), an […]